ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,567 | -33.7% | 80,392 | -0.8% | 0.01% | -22.2% |
| Q2 2023 | $14,436 | +8.0% | 81,012 | -0.0% | 0.02% | 0.0% |
| Q1 2023 | $13,367 | +8.6% | 81,029 | +3.7% | 0.02% | +5.9% |
| Q4 2022 | $12,309 | -99.9% | 78,160 | +1.5% | 0.02% | 0.0% |
| Q3 2022 | $11,601,000 | +15.7% | 77,033 | +26.3% | 0.02% | +30.8% |
| Q2 2022 | $10,030,000 | -25.8% | 61,012 | +0.4% | 0.01% | -7.1% |
| Q1 2022 | $13,525,000 | -3.9% | 60,748 | +2.5% | 0.01% | 0.0% |
| Q4 2021 | $14,068,000 | +158.0% | 59,274 | +153.7% | 0.01% | +133.3% |
| Q3 2021 | $5,452,000 | +14.4% | 23,362 | +0.9% | 0.01% | +20.0% |
| Q2 2021 | $4,764,000 | +0.2% | 23,150 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $4,756,000 | -21.9% | 23,150 | -18.5% | 0.01% | -28.6% |
| Q4 2020 | $6,090,000 | +10.0% | 28,393 | -6.3% | 0.01% | 0.0% |
| Q3 2020 | $5,536,000 | -42.5% | 30,293 | -42.0% | 0.01% | -41.7% |
| Q2 2020 | $9,622,000 | -30.1% | 52,205 | -23.5% | 0.01% | -42.9% |
| Q1 2020 | $13,769,000 | +25.3% | 68,242 | +16.2% | 0.02% | +61.5% |
| Q4 2019 | $10,989,000 | +14.3% | 58,727 | -2.5% | 0.01% | +8.3% |
| Q3 2019 | $9,612,000 | -41.7% | 60,227 | -7.9% | 0.01% | -42.9% |
| Q2 2019 | $16,475,000 | +13.8% | 65,401 | +8.1% | 0.02% | +10.5% |
| Q1 2019 | $14,480,000 | +9.2% | 60,501 | +4.8% | 0.02% | 0.0% |
| Q4 2018 | $13,258,000 | -49.0% | 57,737 | -37.2% | 0.02% | -38.7% |
| Q3 2018 | $25,976,000 | -1.2% | 91,869 | +2.6% | 0.03% | -6.1% |
| Q2 2018 | $26,303,000 | +38.6% | 89,572 | +19.2% | 0.03% | +37.5% |
| Q1 2018 | $18,973,000 | +25.0% | 75,172 | +7.0% | 0.02% | +33.3% |
| Q4 2017 | $15,178,000 | +15.3% | 70,269 | -0.8% | 0.02% | +5.9% |
| Q3 2017 | $13,166,000 | +6.4% | 70,840 | -1.3% | 0.02% | +6.2% |
| Q2 2017 | $12,375,000 | +20.1% | 71,739 | +6.3% | 0.02% | +14.3% |
| Q1 2017 | $10,300,000 | +29.2% | 67,456 | +24.7% | 0.01% | +27.3% |
| Q4 2016 | $7,970,000 | +332.0% | 54,090 | +270.5% | 0.01% | +266.7% |
| Q3 2016 | $1,845,000 | +12.1% | 14,600 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $1,646,000 | -15.2% | 14,600 | -21.7% | 0.00% | -33.3% |
| Q1 2016 | $1,941,000 | -59.1% | 18,645 | -55.7% | 0.00% | -57.1% |
| Q4 2015 | $4,745,000 | +3.7% | 42,070 | +0.7% | 0.01% | 0.0% |
| Q3 2015 | $4,575,000 | -35.1% | 41,785 | -43.3% | 0.01% | -30.0% |
| Q2 2015 | $7,052,000 | +28.5% | 73,718 | +25.1% | 0.01% | +25.0% |
| Q1 2015 | $5,489,000 | -7.3% | 58,934 | -18.5% | 0.01% | -11.1% |
| Q4 2014 | $5,924,000 | +195.9% | 72,335 | +131.8% | 0.01% | +200.0% |
| Q3 2014 | $2,002,000 | +5.5% | 31,200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,897,000 | +4.9% | 31,200 | +3.3% | 0.00% | 0.0% |
| Q1 2014 | $1,808,000 | -6.0% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,924,000 | -6.2% | 30,200 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $2,051,000 | -5.7% | 30,200 | 0.0% | 0.00% | -25.0% |
| Q2 2013 | $2,176,000 | – | 30,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |